Dose-related Effects of the Acetylcholinesterase Inhibitor Tacrine on Cocaine and Food Self-administration in Rats
Overview
Authors
Affiliations
Rationale: Acetylcholine (ACh) is involved in brain reward and learning functions and contributes to opiate- and psychostimulant-motivated behaviors. Tacrine is a centrally acting, reversible cholinesterase inhibitor that also inhibits monoamine oxidase (MAO) and blocks reuptake of dopamine (DA) and serotonin.
Objectives: To determine the effects of pretreatment with tacrine on self-administration of cocaine and nondrug reinforcers.
Materials And Methods: Male Wistar rats were trained to self-administer cocaine under a fixed-ratio-5 (FR-5) schedule during 2-h multiple-component sessions in which 0.1, 0.2, and 0.4 mg/kg per injection of cocaine were each available for 40 min. Other animals self-administered 45 mg food pellets under FR-30 or 20% Ensure (liquid food) under FR-5 in amounts of 30, 60, or 120 microl. Vehicle or tacrine was administered as single intravenous doses 20 min before self-administration of cocaine, food pellets, or liquid food.
Results: Although pretreatment with 0.032 mg/kg of tacrine increased self-administration of food pellets, pretreatment with higher doses of tacrine attenuated self-administration of cocaine, food pellets, or liquid food. Tacrine's ED50 value for attenuating self-administration of 0.1 mg/kg per injection of cocaine was more than sixfold lower than values for attenuating liquid food- or food pellet-reinforced behavior. However, ED50 values for attenuating self-administration of higher doses of cocaine were similar to those observed for 30 or 60 microl of liquid food.
Conclusions: Tacrine can selectively attenuate self-administration of low-dose cocaine, but its effects on higher doses of cocaine are similar to its ability to decrease self-administration of nondrug reinforcers.
Grasing K, Xu H, Idowu J Behav Pharmacol. 2019; 30(6):478-489.
PMID: 30724803 PMC: 6679828. DOI: 10.1097/FBP.0000000000000472.
Grasing K Behav Brain Res. 2016; 312:148-62.
PMID: 27316344 PMC: 4970908. DOI: 10.1016/j.bbr.2016.06.022.
Grasing K, Yang Y, He S Pharmacol Res. 2015; 97:40-7.
PMID: 25890194 PMC: 4465028. DOI: 10.1016/j.phrs.2015.04.003.
Thomsen M, Fulton B, Caine S Psychopharmacology (Berl). 2013; 231(3):469-79.
PMID: 23995301 PMC: 3947149. DOI: 10.1007/s00213-013-3256-9.
Liu X Psychopharmacology (Berl). 2013; 230(2):203-13.
PMID: 23712602 PMC: 3797181. DOI: 10.1007/s00213-013-3145-2.